New Products & Services

Removable stent prevents post-RP bladder strictures

Caesarea, Israel-Allium Group's bladder neck stent is comprised of a super-elastic structure that is inserted into the posterior urethra of patients after radical prostatectomy or radical cystoprostatectomy to prevent stenosis at the anastomosis site. The manufacturer notes the stent has not yet received FDA approval, but physicians can apply for permission to use it as an orphan device to prevent post-radical prostatectomy recurrent strictures.

Mesh slings aid in anterior, posterior vaginal repair

Raynham, MA-Mpathy Medical's Restorelle A and Restorelle P are designed for minimally invasive anterior and posterior pelvic organ prolapse repairs, respectively. Designed by a surgeon, Restorelle uses a physiologically compatible mesh-Smartmesh Technology-that is non-palpable, maintains vaginal elasticity, and delivers near-zero erosion rates, optimal tissue incorporation, and 71% more mature type 1 collagen growth. Absence of blind needle passage and long mesh tails during single-incision installation minimize tissue trauma for faster recovery and reduced complications. Both products have 501(k) clearance for marketing in the U.S.

For more information, visit http://www.mpathymedical.com/.

Micro-spring scissors boast improved grip, control in the OR

Stow, OH-Spectrum Surgical Instruments' honeycomb-handle micro-spring scissors feature a specially designed handle for better tactile feel and control. According to the manufacturer, the honeycomb design also makes the scissors easier to clean than standard serrated-handle micro scissors. Available in several styles and sizes, the device is made of premium German stainless steel.

Genome-based test predicts PCa recurrence, metastasis

Mukilteo, WA-ProScan, from CombiMatrix Corp., probes for specific genomic loci of which copy number gains and losses have been shown to correlate with risk of recurrence and metastasis in patients who have undergone prostatectomy. The additional probes enhance the company's solid tumor array platform design, enabling whole-genome tumor profiling (genomic grading) while providing information about the copy-number status of specific disease-associated loci.

For more information, visit http://www.cmdiagnostics.com/.